Login to Your Account

Long-lasting pill design nets Lyndra $23M series A

By Michael Fitzhugh
Staff Writer

Thursday, April 13, 2017

Lyndra Inc., a company developing gelatin capsule pills that can last a week or more, has closed a $23 million series A financing it said will help it ramp up development, manufacturing and preparations for phase I studies this year.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription